Press Releases

Oct 14, 2003 HEMISPHERX BIOPHARMA EXPANDS SARS PREVENTION/TREATMENT INITIATIVE

Sep 15, 2003 HEMISPHERX BIOPHARMA REPORTS ON ANNUAL MEETING

Sep 15, 2003 HEMISPHERX BIOPHARMA REPORTS ON ANNUAL MEETING

Sep 04, 2003 HEMISPHERX BIOPHARMA SIGNS AGREEMENT WITH GUANGDONG MEDICINE GROUP CORPORATION

Aug 20, 2003 HEMISPHERX BIOPHARMA SECOND QUARTER EARNINGS ANNOUNCED

Aug 18, 2003 HEMISPHERX BIOPHARMA ENTERS INTO SALES AND MARKETING AGREEMENT WITH ENGITECH FOR ALFERON N

Aug 11, 2003 HEMISPHERX BIOPHARMA ENTERS INTO AGREEMENT WITH THE JOHANN WOLFGANG GOETHE UNIVERSITY, INSTITUTE OF VIROLOGY

Aug 04, 2003 HEMISPHERX BIOPHARMA RECEIVES NEW PATENTS FOR ORAL DOSED BROAD-SPECTRUM IMMUNE ACTIVATORS

Jul 29, 2003 HEMISPHERX REPORTS AMPLIGEN PREVENTS DESTRUCTION OF NERVE CELLS AND INCREASES SURVIVAL RATES IN FLAVIVIRUS INFECTION

Jul 15, 2003 HEMISPHERX REPORTS NEW HIV TREATMENT DATA ON AMPLIGEN AT THE 2nd IAS CONFERENCE ON HIV PATHOGENESIS AND TREATMENT

60 61 62 63 64 65 66 67 68 69 70

<< < > >>